Herbert J. Conrad

Insider Reports History

Location
Hampton, NJ
Signature
/s/ Sam Martin, attorney-in-fact for Herbert J. Conrad
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Herbert J. Conrad:

Company Role Class Num Shares Value Price $ Report Date Ownership
Matinas BioPharma Holdings, Inc. Director Stock option (right to buy) 437,244 01 Nov 2023 Direct
Celldex Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 16,500 05 Jun 2025 Direct
Celldex Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 16,500 13 Jun 2024 Direct

Insider Reports Filed by Herbert J. Conrad

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLDX Celldex Therapeutics, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:08
CLDX Celldex Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:03
MTNB Matinas BioPharma Holdings, Inc. 01 Nov 2023 1 $0 4 Director 03 Nov 2023, 16:49
CLDX Celldex Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:08
MTNB Matinas BioPharma Holdings, Inc. 14 Nov 2022 1 $0 4 Director 16 Nov 2022, 20:34
CLDX Celldex Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:08
MTNB Matinas BioPharma Holdings, Inc. 01 Nov 2021 1 $0 4 Director 02 Nov 2021, 16:17
MTNB Matinas BioPharma Holdings, Inc. 04 Aug 2021 4 $0 4 Director 05 Jul 2022, 18:00
MTNB Matinas BioPharma Holdings, Inc. 07 Jul 2021 2 $0 4 Director 09 Jul 2021, 17:30
MTNB Matinas BioPharma Holdings, Inc. 19 Jun 2021 3 $0 4 Director 24 Jun 2021, 17:37
CLDX Celldex Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 16:19
MTNB Matinas BioPharma Holdings, Inc. 13 Jan 2021 6 $0 4 Director 24 May 2021, 17:30